Quantcast
Last updated on April 21, 2014 at 8:55 EDT

Latest Ikaria Stories

2014-01-07 12:27:28

HAMPTON, N.J., Jan. 7, 2014 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients in the hospital and ICU settings, today announced that its Chairman and CEO, Daniel Tasse, will present at the 2014 Biotech Showcase(TM) conference. Mr. Tasse's presentation will be given on Tuesday, January 14, 2014 at 2:30 p.m. PST in the Hearst Room on the third floor of...

2013-04-16 12:26:57

HAMPTON, N.J., April 16, 2013 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, today announced that its Chairman and CEO, Daniel Tasse, will present at the 2013 Biotechnology Industry Organization (BIO) Business Forum and International Convention taking place April 22-25, 2013 at McCormick Place in Chicago, IL. Mr. Tasse's presentation will be given on...

2008-07-28 09:00:31

CLINTON, N.J., July 28 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for inhaled carbon monoxide for use in the reduction of the incidence and severity of delayed graft function (DGF) in patients undergoing solid organ transplantation. Ralf Rosskamp, M.D., Executive Vice President of Research and Development for Ikaria, commented, "The...

2008-06-19 09:01:09

Ikaria, through its subsidiary Ino Therapeutics, has announced that the Japan's Ministry of Health, Labor, and Welfare's Council on Drugs and Food Sanitation has recommended approval of the company's INOflo for inhalation. INOflo (brandname INOmax in the US) will be indicated for the treatment of newborns who suffer from hypoxic respiratory failure, a potentially life-threatening condition that keeps babies' lungs from delivering enough oxygen to their bodies. INOflo is expected to be...